The conference will be a congregation of venture
capitalists, private equity investors, corporate investors, strategic
investors, angel investors, institutional investors, investment
bankers, commercial bankers, biotech and life sciences company
executives, entrepreneurs, analysts, thought leaders, scientists,
researchers, academicians, and service providers.
d-Conference: Before the conference,
all registered delegates will be requested to submit issues for
panel discussion.
The 2004 & 2005 conference were attended by
delegates from France, India, South Africa, Canada, Sweden, Switzerland,
UK, South Korea, Russia, China and the USA, among others. Following
is a sample listing from the past conferences.
President & CEO- Serenex, Inc.; CEO-Transave,
Inc.; CEO - Digital Bio (South Korea); CEO -
Med Discovery (Switzerland); Director - Exgenis (UK);
CEO - Congenix (Russia); Managing Director- The Carlyle
Group; Professor Of Medicine- Columbia University;
General Partner- EDF Ventures; Partner - Phillips
Nizer, LLP; Professor Of Medicine- Colorado University,
General Partner- MPM Capital; Bioinformatics Executive-Microsoft;
General Partner- Flagship Ventures; President - Digital
Bio Technology; Managing Director-Catalyst Health and
Technology Partners; CEO - PKPD; Managing Director,
Life Sciences- Hercules Technology Growth Capital; CFO.-
Serenex, Inc.; Managing General Partner- Boston Millennia
Partners; Chairman, President & CEO - Locus Pharmaceuticals,
Inc; Managing Partner- Cross Atlantic Partners;
Executive- Equinox Group; General Partner- EuclidSR
Partners; Controller -Fast Track Systems, Inc.;
General Partner- Seaflower Ventures; Director - Gerson
Lehrman Group; General Partner- Domain Associates, LLC;
Director- Digital Bio Technology; General Partner- Spray
Venture Partners; Startup Executive (M.D., Ph.D) - Harvard
Medical School; General Partner- SV Life Sciences Advisers;
Managing General Partner- Boston Millennia Partners;
Managing Partner/ Founder- Arboretum Ventures; Partner-
Davis Wright Tremaine LLP; Partner- Stroock &
Stroock & Lavan; Partner- A.M. Pappas & Associates;
Partner- MedVenture Associates; President- Janus
Pharma; General Partner- New Leaf Venture Partners L.L.C;
President & CEO- Serenex, Inc.; President & CEO-
BioTrove; Managing Partner- Easton Capital;
President & COO- Pharmos Corporation; Principal-
The Aurora Funds; Principal- Cannon Design; Principal-
Bear Stearns Health Innoventures; Principal- Care
Capital; Sr. Planner-Cannon Design; Sr. Vice President-
Life Sciences Greenhouse; Sr. Vice President- William
Gallagher Associates; Managing Director - Red Abbey
Venture Partners; Biotech Entrepreneur - Princeton
University; Biotech Entrepreneur - Brandeis University;
Tech. Advisor & Patent Agent- Stroock & Stroock &
Lavan; Vice President- Cytel Inc.; Vice President-
Frazier Healthcare Ventures; VP Bus. Development &
Field Operations- BioTrove; Managing Director- Cogene
Ventures; VP of Research & Development/ CSO- Locus
Pharmaceuticals, Inc; Investment Partner- Mitsui &
Co. Venture Partners, Inc; VP, Business Development- Chugai
Pharma USA; Managing Director- KBL Healthcare Ventures;
CEO - Med Discovery; CEO -Transave Inc.;
Partner - Ropes & Gray, LLP; Managing Partner-
Ascent Biomedical Ventures; Partner - Davis
Wright Tremaine, LLP; CEO - Xcellerex;
SVP, Director - Gerson Lehrman Group; Corporate Dev.
Exe- Serenex, Inc.;and more.
Register
Now!!
_____________________________
Program schedule, date,
location and speakers are subject to change